Bureau Veritas
Bureau Veritas reported first-quarter 2026 revenue of 1.547 billion euros, down 0.8% compared to the first quarter of 2025. The group delivered organic growth of 4.5%. The company now anticipates moderate single-digit organic revenue growth (4-6%), compared to previous guidance of moderate-to-high single-digit growth (between 4-6% and 7-9%). Its adjusted operating margin target remains unchanged and is expected to improve at constant exchange rates. Cash flow forecasts also remain unchanged and are still expected at a high level.

Danone 
Danone unveiled revenue of 6,708 million euros for the first quarter of 2026, down 2% on a reported basis, penalized by an unfavorable currency effect of -5.6%, and despite positive scope effects (+0.5%) and the contribution of hyperinflation (+0.3%). On a like-for-like basis, the food group's quarterly revenue rose by 2.7%, driven by a 1.5% increase in volume/mix and a price effect of +1.2% "in a challenging environment." The group confirmed its 2026 targets, in line with its medium-term ambition, namely like-for-like revenue growth between +3% and +5% and recurring operating income growth outstripping revenue growth. 

DMS Group
In the first quarter of 2026, DMS Group recorded consolidated revenue of 10 million euros, down 8% compared to the first quarter of 2025. In an extremely complex international market and following a record fourth quarter of 2025, the start of 2026 was marked by a temporary decline in activity for the French company specializing in medical diagnostic imaging systems. This quarterly trend does not, however, prejudge the annual activity level, with revenue expected to grow in the second quarter of 2026 and over the full 2026 fiscal year.

Drone Volt
Drone Volt, a French manufacturer of professional drones and a technological player in aerial robotics, announced its intention to increase its capacities in France and internationally to meet growing demand for its service activities. According to the group, all operational indicators point to a rapid ramp-up of these activities, particularly with the intensification of missions on critical infrastructure, the scaling up of existing contracts, and the progressive activation of new markets.

Eurofins Scientific
Eurofins Scientific posted revenue of 1,789 million euros for the first three months of 2026, representing a 1.3% increase on a reported basis and organic growth of 2.6%, despite "temporary headwinds." This organic growth (which includes a +0.1% adjustment for public working days) and favorable scope effects were largely offset by a negative currency effect of -4.8%. Eurofins reiterated its targets for 2026, as well as its medium-term and 2027 objectives. For the current year, it notably targets "mid-single-digit" organic growth and an adjusted EBITDA margin higher than the 22.5% achieved in 2025.

FDJ United
Supported by generally resilient activity but penalized by a heavier tax environment, FDJ United recorded a slight decline in revenue in the first quarter, while maintaining positive momentum in its gross gaming revenue. Revenue amounted to 895 million euros for the first quarter, down 3.2% on a reported basis. This contraction includes a negative impact of 24 million euros related to increased gaming taxes, the group noted. Ultimately, gross gaming revenue (GGR) rose by 1% to 2,175 million euros. For 2026, FDJ UNITED adjusted its guidance and now targets a slight increase in GGR but a slight decline in revenue, incorporating an estimated tax impact of nearly 90 million euros. The group anticipates a gradual improvement in the performance of the "Betting and Online Gaming" division, with a return to GGR growth in the second half, and confirmed a recurring EBITDA margin target of between 23% and 24%.

Haffner Energy
Haffner Energy announced the signing of a landmark Memorandum of Understanding (MoU) on April 16, 2026, between the Government of Maharashtra (India), JW Global Group, and The Seed Consortium Partners. This agreement represents approximately 15 billion euros (165,000 crore rupees) of investment spread across four large-scale infrastructure and clean technology projects, two of which are based on Haffner Energy's technologies. These four projects will be developed on 275 hectares located on both sides of the Bhima River, near the Ujani Dam Reservoir in the State of Maharashtra.

Ipsen
Ipsen announced that the European Commission has granted conditional marketing authorization for Ojemda (tovorafenib) as the first targeted therapy for relapsed or refractory pediatric low-grade glioma, regardless of BRAF gene alteration. It is thus approved as a monotherapy to treat patients aged 6 months and older with pediatric low-grade glioma harboring a BRAF gene fusion or rearrangement, or a BRAF V600 mutation, and who have progressed after one or more prior systemic treatments.


Paref
Paref's consolidated revenue amounted to 6.2 million euros in the first quarter of 2026, up 5% compared to the first quarter of 2025. Gross rental income rose significantly, driven by the contribution of the new lease signed on the Tempo asset in Paris and the positive impact of rent indexation. The portfolio's weighted average lease break (WALB) stood at 4.03 years, compared to 4.23 years at the end of 2025.

Rexel
Rexel posted sales of 4,736.9 million euros for the first three months of 2026, down 1.8% on a reported basis due to the calendar effect and a negative currency effect, but up 3.4% on a constant and same-day basis. In the current uncertain environment, Rexel confirmed its annual targets for 2026, namely constant-day sales growth of 3% to 5%, an adjusted recurring EBITA margin of approximately 6.2%, and free cash flow conversion exceeding 65%.

Sanofi
Sanofi announced that the U.S. health authorities (FDA) had approved a supplemental Biologics License Application for Tzield, extending its indication from young children aged 8 and older to those aged 1 and older. This treatment is intended to delay the onset of Stage 3 type 1 diabetes (T1D) in patients diagnosed with Stage 2 T1D. This approval was granted under the FDA's priority review process and is based on one-year interim data from the ongoing PETITE-T1D Phase 4 study evaluating the safety and pharmacokinetics of Tzield in young children.


Solocal
Group revenue amounted to 74 million euros in the first quarter of 2026, down 10.7% compared to the first quarter of 2025, and down 6.3% compared to the fourth quarter of 2025. The order backlog showed a 5.2% increase, representing 259.2 million euros at the end of March 2026, compared to 246.3 million euros as of December 31, 2025. Solocal confirmed its target of reporting higher fourth-quarter revenue. Regarding profitability, Solocal confirmed its objective of further profitability improvement, with an EBITDA margin expected around 20% in 2026.

Vusion
On an adjusted basis, Vusion's revenue reached 294 million euros in the first quarter of 2026, up 26% year-on-year. During this period, global order intake stood at 316 million euros, in line with expectations. Revenue from VAS (Value Added Services) reached 51 million euros, showing strong growth of 53%. Vusion confirmed the growth and profitability targets for the 2026 fiscal year announced during the publication of its annual results on February 26. Annual adjusted revenue growth is still expected to be between 15% and 20% at constant exchange rates and customs duties. This adjusted revenue is expected to be fairly balanced between the first and second halves (both around 800 to 900 million euros), albeit with a stronger growth rate in the first half than in the second.